Inventor · disambiguated record
David S. Weinstein
Also filed as: WEINSTEIN DAVID · WEINSTEIN DAVID S
37 granted patents·8 pending applications·270 citations·filing 2000–2025
97Inventor score
Top patents by PatentIndex Score
45 records- 0197US9505748B2Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responsesBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Nov 29, 2016·53 cites·9 claims
- 0296US11021475B2Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responsesBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jun 1, 2021·8 cites·16 claims
- 0396US10000480B2Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responsesBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jun 19, 2018·20 cites·14 claims
- 0495US11021462B2Sulfone pyridine alkyl amide-substituted heteroaryl compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jun 1, 2021·6 cites·28 claims
- 0594US11787779B2Sulfone pyridine alkyl amide-substituted heteroaryl compoundsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Oct 17, 2023·2 cites·4 claims
- 0694USRE47929EAmide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responsesBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Apr 7, 2020·19 cites·39 claims
- 0793US7326705B2Heterocyclic sodium/proton exchange inhibitors and methodBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Feb 5, 2008·24 cites·18 claims
- 0892US10294256B2Phosphine oxide alkyl amide substituted heteroaryl compounds as modulators of IL-12, IL-23 and/or IFN alpha responsesBRISTOL MYERS SQUIBB CO·Filed 2017·Granted May 21, 2019·5 cites·10 claims
- 0992US9663467B2Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responsesBRISTOL MYERS SQUIBB CO·Filed 2014·Granted May 30, 2017·21 cites·7 claims
- 1092US6887870B1Heterocyclic sodium/proton exchange inhibitors and methodBRISTOL MYERS SQUIBB CO·Filed 2000·Granted May 3, 2005·51 cites·28 claims
- 1190US9987266B2Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responsesBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jun 5, 2018·9 cites·1 claims
- 1288US9315494B2Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responsesBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Apr 19, 2016·14 cites·11 claims
- 1387US9540333B2Alkyl amide-substituted pyrimidine compounds useful in the modulation of IL-12, IL-23 and/or IFNαBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 10, 2017·11 cites·16 claims
- 1487US2025243193A1Amide-substituted heterocyclic compounds useful as modulators of il-12, il-23 and/or ifn alpha responsesBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 1586US12365667B2Sulfone pyridine alkyl amide-substituted heteroaryl compoundsBRISTOL MYERS SQUIBB CO·Filed 2023·Granted Jul 22, 2025·0 cites·13 claims
- 1684US7253283B2Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Aug 7, 2007·6 cites·15 claims
- 1783US2025304555A1Sulfone pyridine alkyl amide-substituted heteroaryl compoundsBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 1882US7888381B2Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity, and use thereofBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Feb 15, 2011·6 cites·6 claims
- 1980US8034940B2Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Oct 11, 2011·4 cites·11 claims
- 2079US10273237B2Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN-α responsesBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Apr 30, 2019·4 cites·2 claims
- 2176US11597721B2Heterocyclic compounds comprising pyridine useful as modulators of IL-12, IL-23 and/or IFNα responsesBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Mar 7, 2023·1 cites·11 claims
- 2276US2022356180A1Amide-substituted heterocyclic compounds useful as modulators of il-12, il-23 and/or ifn alpha responsesBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 2371US2025188040A1Pharmaceutical compositions comprising wrn helicase inhibitorsVIVIDION THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2469US12187685B2Pharmaceutical compositions comprising WRN helicase inhibitorsVIVIDION THERAPEUTICS INC·Filed 2023·Granted Jan 7, 2025·0 cites·23 claims
- 2569US7351727B2Inhibitors of 15-lipoxygenaseBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Apr 1, 2008·4 cites·4 claims
- 2669US2024067612A1Pharmaceutical compositions comprising wrn helicase inhibitorsVIVIDION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2768US10479793B2Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responsesBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Nov 19, 2019·1 cites·3 claims
- 2861US2025011291A1Keap1 inhibitors and uses thereofVIVIDION THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2961US2025332156A1Pharmaceutical compositions comprising wrn helicase inhibitorsVIVIDION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3061US2024226114A1Inhibitors and uses thereofVIVIDION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3158US12479831B2Substituted N(-methyl-D3)pyridazine-3-carboxamide or M-(methyl-D3)-nicotinamide compounds as IL-12, IL-23 and/or IFNα modulatorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Nov 25, 2025·0 cites·6 claims
- 3258US7432271B2Pyrazolyl inhibitors of 15-lipoxygenaseBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Oct 7, 2008·1 cites·4 claims
- 3356US7544808B2Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Jun 9, 2009·0 cites·14 claims
- 3453US9796720B2Imidazole-derived modulators of the glucocorticoid receptorBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Oct 24, 2017·0 cites·10 claims
- 3553US7534804B2Benzoxazole inhibitors of 15-lipoxygenaseBRISTOL MYERS SQUIBB CO·Filed 2006·Granted May 19, 2009·0 cites·8 claims
- 3651US10781215B2Heterobicyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responsesBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Sep 22, 2020·0 cites·1 claims
- 3750US8304539B2Fused heteroaryl modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofDUAN JINGWU·Filed 2009·Granted Nov 6, 2012·0 cites·19 claims
- 3849US11299494B2Substituted imidazo[1,2-b]pyridazines as interleukin-23 and interferon-α modulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Apr 12, 2022·0 cites·20 claims
- 3947US7429611B2Indole inhibitors of 15-lipoxygenaseBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Sep 30, 2008·0 cites·4 claims
- 4046US9663469B2RORγ modulatorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted May 30, 2017·0 cites·6 claims
- 4146US9593113B2Imide and acylurea derivatives as modulators of the glucocorticoid receptorBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Mar 14, 2017·0 cites·15 claims
- 4245US9725443B2RORγ modulatorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 8, 2017·0 cites·2 claims
- 4345US7605264B2Heterocyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Oct 20, 2009·0 cites·15 claims
- 4445US7317032B2Imidazolyl inhibitors of 15-lipoxygenaseBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Jan 8, 2008·0 cites·4 claims
- 4543US7361654B2Substituted heteroaryl amide modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Apr 22, 2008·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when David S. Weinstein files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →